Outlook Therapeutics Provides Business Update and Reports Second Quarter Financial Results for Fiscal 2019 GlobeNewswire CRANBURY, N.J., May 15, 2019 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) today reported business highlights and … … Continue reading →
BISON CAPITAL ACQUISITION CORP. ANNOUNCES CLOSING OF ITS BUSINESS COMBINATION WITH XYNOMIC PHARMACEUTICALS, INC. GlobeNewswire New York, NY, May 15, 2019 (GLOBE NEWSWIRE) — Bison Capital Acquisition Corp. (NASDAQ: BCAC) (“BCAC” or the “Company”) today announced that it has … … Continue reading →
AMERI100 Announces First Quarter 2019 Financial Results Nasdaq:AMRH GlobeNewswire ATLANTA, May 14, 2019 (GLOBE NEWSWIRE) — AMERI Holdings, Inc. (NASDAQ: AMRH) (“Ameri100” or the “Company”), a specialized SAP® cloud, digital … … Continue reading →
AMERI100 Announces First Quarter 2019 Financial Results Nasdaq:AMRH – GlobeNewswire Read More »
Infrastructure and Energy Alternatives, Inc. Announces $50 Million Equity Commitment GlobeNewswire INDIANAPOLIS, May 14, 2019 (GLOBE NEWSWIRE) — Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) (“IEA” or the “Company”), a leading … … Continue reading →
STRATA Skin Sciences Announces Preliminary First Quarter 2019 Financial Results and Updates Yahoo Finance Unaudited First Quarter 2019 total revenue of $7.4 million increased 15% year-over-year. Recurring revenue of $5.3 million increased 17% year-over-year … Continue reading →
Form POS AM CATABASIS PHARMACEUTICAL StreetInsider.com Use these links to rapidly review the document. TABLE OF CONTENTS. Table of Contents. As Filed with the Securities and Exchange Commission on May 14, … … Continue reading →
Form POS AM CATABASIS PHARMACEUTICAL – StreetInsider.com Read More »
Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2019 PRNewswire HOUSTON, May 14, 2019 /PRNewswire/ — Moleculin Biotech, Inc. (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company … … Continue reading →
Form 424B5 Arch Therapeutics, Inc. StreetInsider.com Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Filed Pursuant to Rule 424(b)(5). Registration … … Continue reading →
Form 424B5 Arch Therapeutics, Inc. – StreetInsider.com Read More »
Key Executives Behind Kaminak Launch Tectonic Metals into the Public Arena by Initiating a C$5M Financing Associated with a Direct Listing on TSXV Canada NewsWire NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, May 13, 2019 /CNW/ – Tectonic … … Continue reading →
Trovagene Announces Equity Investment of $1.5 Million at Premium to Market Price from Institutional Investor, Lincoln Park Capital Yahoo Finance Additional funding further extends runway for Trovagene to accelerate clinical development of onvansertib for the treatment of cancers where new therapeutic … … Continue reading →
